Identifying the most critical side effects of antidepressant drugs: a new model proposal with quantum spherical fuzzy M-SWARA and DEMATEL techniques
- PMID: 39342208
- PMCID: PMC11438092
- DOI: 10.1186/s12911-024-02692-z
Identifying the most critical side effects of antidepressant drugs: a new model proposal with quantum spherical fuzzy M-SWARA and DEMATEL techniques
Abstract
Identifying and managing the most critical side effects encourages patients to take medications regularly and adhere to the course of treatment. Therefore, priority should be given to the more important ones, among these side effects. However, the number of studies that make a priority examination is limited. There is a need for a new study that determines which of these effects are more priority to increase the quality of the treatment. Accordingly, this study aims to define the most important side effects of antidepressant drugs with a novel model. Quantum Spherical fuzzy M-SWARA technique is considered to compute the importance weights of the items. The main contribution of this study is that the most critical side effects can be understood for antidepressant drugs by establishing a novel decision-making model. The findings demonstrate that psychological side effects are defined as the most critical side effects of antidepressant drugs. Furthermore, physical side effects also play a key role in this condition. Side effects in antidepressant treatment have a great impact on the effectiveness of treatment and patient compliance.
Keywords: Antidepressant drugs; Correct drug use; Fuzzy logic; Multi-criteria decision making; Side effect.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Blair L, Heydon-Hatchett V, Davies G, Guy A, Davies J. Therapists’ perspectives on working with clients taking psychiatric drugs: findings from a mixed‐methods survey. Counselling Psychother Res. 2021;21(4):1008–20.
-
- Friedman JH. Movement disorders induced by psychiatric drugs that do not block dopamine receptors. Parkinsonism Relat Disord. 2020;79:60–4. - PubMed
-
- Lehmann P. Paradigm shift: treatment alternatives to psychiatric drugs, with particular reference to low-and middle-income countries 1. The Routledge Handbook of International Development, Mental Health and Wellbeing. Routledge; 2019. pp. 251–69.
-
- Powell JG, Garland S, Preston K, Piszczatoski C. Brexanolone (Zulresso): finally, an FDA-approved treatment for postpartum depression. Ann Pharmacother. 2020;54:157–63. 10.1177/1060028019873320. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
